We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

105 hedge funds and large institutions have $385M invested in Perspective Therapeutics in 2024 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 33 increasing their positions, 16 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 16

52.32% more ownership

Funds ownership: 5.01% → 57.32% (+52%)

30% more capital invested

Capital invested by funds: $296M → $385M (+$88.9M)

2% more funds holding

Funds holding: 103 → 105 (+2)

8% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 48

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
105
Holders Change
+2
Holders Change %
+1.94%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
52
Increased
33
Reduced
16
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$45.3M
2
APM
Avidity Partners Management
Texas
+$43.9M
3
BlackRock
BlackRock
New York
+$39M
4
CC
Commodore Capital
New York
+$36.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$16.5M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.5M
2
HBT
Hills Bank & Trust
Iowa
-$12.3M
3
LCM
Laurion Capital Management
New York
-$10.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$9.41M
5
Marshall Wace
Marshall Wace
United Kingdom
-$8.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
HT
101
Headlands Technologies
Illinois
$1.51K +$2.2K +152 New
PCMC
102
Planning Capital Management Corporation
Pennsylvania
$1.1K +$1.59K +110 New
IAIM
103
International Assets Investment Management
Florida
$897 +$1.3K +90 New
AWM
104
Avior Wealth Management
Nebraska
$508 +$737 +51 New
HBT
105
Hills Bank & Trust
Iowa
– -$12.3M -1,035,831 Closed
LCM
106
Laurion Capital Management
New York
– -$10.6M -891,892 Closed
Goldman Sachs
107
Goldman Sachs
New York
– -$2.38M -199,651 Closed
Hudson Bay Capital Management
108
Hudson Bay Capital Management
Connecticut
– -$1.01M -85,000 Closed
TLP
109
Tri Locum Partners
New York
– -$929K -78,030 Closed
MC
110
Mayo Clinic
Minnesota
– -$862K -72,464 Closed
AI
111
Atom Investors
Texas
– -$656K -55,128 Closed
Susquehanna International Group
112
Susquehanna International Group
Pennsylvania
– -$637K -53,529 Closed
CSS
113
Cubist Systematic Strategies
Connecticut
– -$628K -52,747 Closed
TMWM
114
Taylor & Morgan Wealth Management
Michigan
– -$298K -25,000 Closed
BBA
115
Baker Bros. Advisors
New York
– -$178K -14,979 Closed
HF
116
HRT Financial
New York
– -$145K -12,217 Closed
VF
117
Virtu Financial
New York
– -$138K -11,576 Closed
LP
118
LMR Partners
United Kingdom
– -$137K -11,549 Closed
Balyasny Asset Management
119
Balyasny Asset Management
Illinois
– -$133K -11,172 Closed
PCMH
120
Polymer Capital Management (HK)
Hong Kong
– -$123K -10,377 Closed
Ameriprise
121
Ameriprise
Minnesota
– -$111K -9,320 Closed
Vontobel Holding
122
Vontobel Holding
Switzerland
– -$95.2K -8,000 Closed
CAS
123
CTC Alternative Strategies
Illinois
– -$83.2K -6,990 Closed
Commonwealth Equity Services
124
Commonwealth Equity Services
Massachusetts
– -$57K -4,828 Closed
Mariner
125
Mariner
Kansas
– -$56.9K -4,778 Closed
3 4
5
6 7

CATX Hedge Fund Activity: Q2 2024 in Review

105 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2024, worth a combined $385M — up 30% from $296M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new CATX positions and 48 closed out — a net gain of 4 holders — while 33 added to existing stakes and 16 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $45.3M. The largest seller was Point72 Asset Management, cutting an estimated $16.5M.

  • 105 institutional investors held Perspective Therapeutics (CATX) as of Q2 2024, up from 103 in Q1 2024.
  • Funds reported $385M of Perspective Therapeutics stock for Q2 2024, up 30% quarter-over-quarter.
  • 52 funds opened new Perspective Therapeutics positions in Q2 2024 and 48 closed out, a net change of +4 holders.
  • The largest Perspective Therapeutics buyer in Q2 2024 was Janus Henderson Group, an estimated $45.3M added.
  • The largest Perspective Therapeutics seller in Q2 2024 was Point72 Asset Management, an estimated $16.5M sold.

Based on aggregated 13F filings for Q2 2024.